Cas:2646-38-0 Sodium chenodeoxycholate manufacturer & supplier

Chemical Name:Sodium chenodeoxycholate

CAS.NO:2646-38-0

Synonyms:sodium sat of chenodeoxycholic acid;Chenodeoxycholate sodium salt;Chenodeoxycholic acid sodium;Chenodeoxycholic acid sodium salt;UNII:6V4571KSKE;sodium chenodexoycholate;5β-Cholanic acid-3α,7α-diol;sodium chenodeoxycholate;sodiumchenodesoxycholate;3α,7α-Dihydroxy-5β-cholanic acid;Chenodeoxycholic acid sodium salt,Chenodesoxycholic acid;ChenodiolChenodesoxycholic acid;chenodesoxycholate de sodium;Sodium (3α,5β,7α)-3,7-dihydroxycholan-24-oate;cenodeoxycholate;Cholan-24-oic acid, 3,7-dihydroxy-, sodium salt, (3α,5β,7α)- (1:1)

Molecular Formula:C₂₄H₃₉NaO₄

Molecular Weight:414.554

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:547.1ºC at 760mmHg

Density:N/A

Index of Refraction:

PSA:80.59000

Exact Mass:414.274597

LogP:3.14320

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like sodium sat of chenodeoxycholic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Cholan-24-oic acid, 3,7-dihydroxy-, sodium salt, (3α,5β,7α)- (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3α,7α-Dihydroxy-5β-cholanic acid Use and application,cenodeoxycholate technical grade,usp/ep/jp grade.

Related News: The Biogen Inc (BIIB.O) drug, Aduhelm, was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer’s, rather than proof that it slows progression of the lethal mind-wasting disease. Sodium chenodeoxycholate manufacturer Due to the cyclic nature of the upstream chemical products of the API, it is expected that the impact of price fluctuations of raw materials on the performance of API companies is unavoidable, but companies with thick product lines and the ability to produce intermediates are expected to minimize the upstream price impact. Sodium chenodeoxycholate supplier The Biogen Inc (BIIB.O) drug, Aduhelm, was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer’s, rather than proof that it slows progression of the lethal mind-wasting disease. Sodium chenodeoxycholate vendor The Biogen Inc (BIIB.O) drug, Aduhelm, was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer’s, rather than proof that it slows progression of the lethal mind-wasting disease. Sodium chenodeoxycholate factory ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment��s chemistry, manufacturing and controls process, but not its safety.